Breast Cancer Resistance Protein (Bcrp) Substrates Interactions

Coadministration increased BCRP substrate exposure, which may increase adverse reactions. Decrease substrate dosage if coadministration unavoidable and minimal concentration changes may lead to serious reactions.

Source: NLP:capmatinib